Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Gajewski

Showing results (21-30 of 236) with videos related to

Pageof 24
Sort By:
Current Opinion in Immunology|April 17, 2013
Cancer immunotherapyThomas F Gajewski, Ton Schumacher
Nature Cancer|February 5, 2022
PAK4 as a cancer immune-evasion targetThomas F Gajewski, Jessica Fessler
Cancer Cell|March 15, 2022
Dietary modulation of the gut microbiome as an immunoregulatory interventionVyara Matson, Thomas F Gajewski
Oncoimmunology|April 10, 2023
Tissue-resident memory T cells in immune-related adverse events: friend or foe?Robin Reschke, Thomas F Gajewski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of CancerLeticia Corrales, Thomas F Gajewski
Cytokine|August 29, 2015
Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapyLeticia Corrales, Thomas F Gajewski
Cytokine & Growth Factor Reviews|January 30, 2015
New perspectives on type I IFNs in cancerThomas F Gajewski, Leticia Corrales
Journal for Immunotherapy of Cancer|September 18, 2015
A new paradigm for tumor immune escape: β-catenin-driven immune exclusionStefani Spranger, Thomas F Gajewski
Oncoimmunology|May 4, 2016
Tumor-intrinsic oncogene pathways mediating immune avoidanceStefani Spranger, Thomas F Gajewski
Current Protocols in Microbiology|September 5, 2008
Diagnosis and treatment of Mycoplasma-contaminated cell culturesHelena Harlin, Thomas F Gajewski
Pageof 24

Showing results (21-30 of 236) with videos related to

Sort By:
Pageof 24
Current Opinion in Immunology|April 17, 2013
Cancer immunotherapyThomas F Gajewski, Ton Schumacher
Nature Cancer|February 5, 2022
PAK4 as a cancer immune-evasion targetThomas F Gajewski, Jessica Fessler
Cancer Cell|March 15, 2022
Dietary modulation of the gut microbiome as an immunoregulatory interventionVyara Matson, Thomas F Gajewski
Oncoimmunology|April 10, 2023
Tissue-resident memory T cells in immune-related adverse events: friend or foe?Robin Reschke, Thomas F Gajewski
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of CancerLeticia Corrales, Thomas F Gajewski
Cytokine|August 29, 2015
Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapyLeticia Corrales, Thomas F Gajewski
Cytokine & Growth Factor Reviews|January 30, 2015
New perspectives on type I IFNs in cancerThomas F Gajewski, Leticia Corrales
Journal for Immunotherapy of Cancer|September 18, 2015
A new paradigm for tumor immune escape: β-catenin-driven immune exclusionStefani Spranger, Thomas F Gajewski
Oncoimmunology|May 4, 2016
Tumor-intrinsic oncogene pathways mediating immune avoidanceStefani Spranger, Thomas F Gajewski
Current Protocols in Microbiology|September 5, 2008
Diagnosis and treatment of Mycoplasma-contaminated cell culturesHelena Harlin, Thomas F Gajewski
Pageof 24